// App-Quantinova.ai

: The Role of Prophylactic Heart Failure Therapy in Duchenne Muscular Dystrophy

Researchers

Presenter

  • A.K. Lal

Principal Investigators

  • C.A. Wittlieb-Weber

  • C.R. Villa

  • J. Conway

  • M.J. Bock

  • K.E. Gambetta

  • K.R. Schumacher

  • S.P. Law

  • S.R. Deshpande

  • S.C. West

  • J.M. Friedland-Little

  • I.D. Lytrivi

  • M.A. McCulloch

  • R.J. Butts

  • K.R. Knecht

  • Z. Ou

  • A.P. Presson

  • J.N. Johnson

Medical Centers

  • Department of Pediatrics, Seattle Childrens Hospital, Seattle, WA

  • Morgan Stanley Children's Hospital, New York, NY

  • Children's Health at UT Southwestern Medical Center, Dallas, TX

  • University of Utah, Salt Lake City, UT

  • Mayo Clinic Children's Center, Rochester, MN

  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL

  • Stollery Children's Hospital, Edmonton, AB, Canada

  • General Pediatrics, Arkansas Childrens Hospital, Little Rock, AR

  • Pediatrics, UVA Children's Hospital, Charlottesville, VA

  • Pediatric Cardiology, Kravis Childrens Hospital at Mount Sinai, New York, NY

  • Children's Natl Medcl Ctr, Washington, DC

  • Children's Hosp of Pittsburgh of UPMC, Pittsburgh, PA

  • Cincinnati Children's Hospital, Cincinnati, OH

  • Golisano Childrens Hospital at URMC, Rochester, NY

  • Pediatrics, C.S. Mott Children's Hospital, Ann Arbor, MI

  • University of Utah/ Primary Childrens Hospital, Salt Lake City, UT

  • Neonatology, Loma Linda University Childrens Hospital, Loma Linda, CA

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

  • Cardiovascular (CVS)

  • Genetic Disorder

Disease

  • Duchenne muscular dystrophy

  • Systolic dysfunction

  • Congestive heart failure

Biomarkers

  • N/A

Drug/Treatment

  • EF-40

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved